Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q2 FY21 results · Jul–Sep 2020
Amrutanjan Health Care reported revenue from operations of ₹92.11 crore (up 23.1% from Q2 FY20) and net profit of ₹23.55 crore (up 180.2% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a standalone basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 92.11 | 74.82 | +23.1% | 46.62 | +97.6% |
| Other income | 4.05 | 1.86 | +117.2% | 2.05 | +97.9% |
| Total income | 96.16 | 76.68 | +25.4% | 48.66 | +97.6% |
| Profit before tax | 31.39 | 12.12 | +158.9% | 8.66 | +262.4% |
| Net profit for the period | 23.55 | 8.40 | +180.2% | 6.43 | +266.4% |
| EPS, basic (₹) | 8.06 | 2.87 | +180.8% | 2.20 | +266.4% |
| Net margin (%) | 25.6 | 11.2 | 13.8 |
Standalone
- Filed with BSE
- 16 Nov 2020, 16:50 IST
- Board meeting
- 12 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE